Results

Total Results: 1,213 records

Showing results for "weight".
Users also searched for: obesity screening

261. Methods Research Report - Meta-Analytical Statistical Inferences for Continuous Measure Outcomes as a Function of Effect Size Metric and Other Assumptions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/statistical-inference_research.pdf
     April 01, 2013 - same metric and has an appropriate sampling variance estimate, the inverse of which is used as the weight … same metric and has an appropriate sampling variance estimate, the inverse of which is used as the weight … estimated they could be used in place of the observed standard deviations in individual studies to weight

262. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - Enoxaparin is a low-molecular-weight heparin that has the advantage of being administered subcutaneously … ○ Adult patients with UA/NSTEMI and comorbid or multimorbid disease:  Subgroups by age, sex, weight … Analyses by subgroup (e.g., age, sex, weight, body mass index, diabetes, heart failure, previous stroke … 60828"[tw] OR "ym466"[tw] 5149 #4 heparin[MeSH] OR heparin[tw] OR (low[tw] AND molecular[tw] AND weight … 60828"[tw] OR "ym466"[tw] 5149 #4 heparin[MeSH] OR heparin[tw] OR (low[tw] AND molecular[tw] AND weight

263. Instrumental Variable Methods in Comparative Safety and Effectiveness Research | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/instrumental-variable-methods/research
     May 14, 2010 - is not predictive of treatment within a subgroup, the treatment effect in that subgroup has a zero weight

264. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - For example, do you need to report both weight and bmi for the general study Thank you for this comment … The example which you provide is reported that way since some studies report weight using the BMI … In Results significant weight gain is reported for the treatment with certain biologics. … Although there was a significant increase in weight from baseline in the etanercept group, the change … in weight in the etanercept group was not compared to the change in weight in the methotrexate group

265. Diabetes Medications for Adults with Type 2 Diabetes: An Update Focused on Monotherapy and Add-on Therapy to Metformin | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/diabetes-update-2015/research-protocol
     January 22, 2015 - FDA-approved diabetes medications (see Table 1 ) for the intermediate outcomes of hemoglobin A1c, weight … FDA-approved diabetes medications (see Table 1 ) for the intermediate outcomes of hemoglobin A1c, weight … A1c (will not evaluate metformin vs. sulfonylureas, evidence is high grade from the prior report) Weight … strength of evidence from our prior evidence report for other outcomes (specifically fracture and weight … We will include studies addressing the following intermediate outcomes for KQ1: Hemoglobin A1c ^ Weight

266. Comparative Effectiveness Review No. 266_Cervical Degenerative Disease Treatment: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-266-cdd-executive-summary.pdf
     November 01, 2023 - Comparative Effectiveness Review No. 266_Cervical Degenerative Disease Treatment: A Systematic Review Comparative Effectiveness Review Number 266 Cervical Degenerative Disease Treatment: A Systematic Review Executive Summary Main Points • Cervical arthroplasty versus anterior cervical discec…

267. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/epilepsy-medicine/research-protocol
     July 01, 2010 - Neurological: insomnia, dizziness, sedation, headache Non-Neurological: aplastic anemia, hepatic failure, weight … Neurological: sedation, dizziness, ataxia, fatigue Non-Neurological: gastrointestinal irritation, weight … slowing, sedation, speech problems, fatigue, paresthesias Non-Neurological: kidney stones, glaucoma, weight … sedation, tremor Non-Neurological: Hepatotoxicity, thrombocytopenia, gastrointestinal irritation, weight … , visual field defects, abnormal vision, diplopia Non-Neurological: nausea, vomiting, diarrhea, weight

268. Comparative Effectiveness and Safety: Emerging Methods - Part I | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/safety-emerging-methods/executive
     September 25, 2007 - Comparative Effectiveness and Safety: Emerging Methods - Part I Executive Summary September 25, 2007 Medical Care Supplement Table of Contents Medical Care 2007 Oct;45(Suppl 2). Editorials Preface Smith SR. Preface. Medical Care . 2007 Oct;45(Suppl 2):S1-S2. The Comparative Effectiveness an…

269. Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-effectiveness/abstract
     February 08, 2011 - Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease Abstract Archived February 8, 2011 Topic Abstract Background Peripheral arterial disease (PAD) is characterized by atherosclerotic stenosis and occlusions in the peripheral arteries and affects up to …

270. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - predicting spontaneous preterm birth, and a pharmaceutical for low birthweight infants to increase weight … interventions intended to target both the woman and fetus (a drug for treating preeclampsia and a weight

271. CERs Report cover (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
     September 01, 2010 - They mentioned the importance of lifestyle interventions including diet, exercise, weight loss, and … Diet/weight control e. Vegetables (type & amount) f. Fruit (type & amount) g. Lifestyle i. … Weight loss as therapy 22.2% (2) 44.4% (4) 33.3% (3) Q14. … Weight loss as therapy 50.0% (6) 16.7% (2) 33.3% (4) Q16. … Birth weight-breast cancer revisited: is the association confounded by familial factors?

272. FRN 39 - Nonoperative and Operative Treatments for Rotator Cuff Tears: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
     February 01, 2013 - FRN 39 - Nonoperative and Operative Treatments for Rotator Cuff Tears: Future Research Needs Future Research Needs Paper Number 39 Nonoperative and Operative Treatments for Rotator Cuff Tears: Future Research Needs Future Research Needs Paper Number 39 Nonoperative and Operative Treatments for Rotator Cuf…

273. MEDLINE Searches (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
     March 01, 2009 - Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large … • Not coherent: the results are not plausible given the weight of epidemiologic or biologic data … Vaginal bleeding, breast symptoms, weight gain, hot flashes. … 5 69 months 28.70 % 45.70% Hot flashes moderately or more bothersome D 2-19 Weight … Rate Weight Gain 2121 2050 34 months 81 NR 109 NR NR NR NR Mortality Total Death- STAR Trial

274. Insulin Delivery and Glucose Monitoring Methods: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
     August 01, 2015 - for daily insulin administration to sustain life, maintain normoglycemia, and maintain normal body weight … population were HbA1c, adherence, nonsevere hypoglycemia, severe hypoglycemia, hyperglycemia, and weight … Table H) Two stakeholders prioritized HbA1c, one prioritized severe hypoglycemia and one ranked weight … 3 * ‡ Adherence 1 * Non-severe hypoglycemia 0 * Severe hypoglycemia 0 * Hyperglycemia 1 * Weight … Two Stakeholders prioritized HbA1c , one prioritized severe hypoglycemia and one ranked weight as the

275. Comparative Effectiveness of First and Second Generation Antipsychotics in the Pediatric and Young Adult Populations | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antipsychotics-children/research-protocol
     June 04, 2010 - They generally have lower risk of motor side effects, but are associated with significant weight gain … Cardiac arrhythmias Agranulocytosis General adverse events include: Extrapyramidal effects Weight … cardiomyopathies and cardiac arrhythmias, agranulocytosis General adverse events: extrapyramidal effects, weight … patient followup), patient baseline characteristics (diagnosis and age at diagnosis, age, sex, race, weight … subjective outcomes (e.g., quality of life or function scales) and objective clinical outcomes (e.g., weight

276. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - methods advocated for management of chronic gout include a combination of lifestyle changes, including weight … ; increasing intakes of cherries, modified milk products, or supplemental vitamin C; or achieving weight … Some dietary advice, such as generic advice to lose weight in overweight and obese patients, has evidence … increasing intakes of cherries, modified milk products, or supplemental vitamin C; or achieving weight … The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the

277. An analytical framework for quantifying components of variability in prescriber decisions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
     April 01, 2010 - is not predictive of treatment within a subgroup, the treatment effect in that subgroup has a zero weight

278. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - • Mirtazapine led to higher weight gains than comparator drugs. … Mean weight gains relative to pretreatment weights ranged from 0.8 kg to 3.0 kg after 6–8 weeks of treatment … The strength of evidence for higher risks of weight gain with mirtazapine than with other antidepressants … Comparative risk of weight High Results from seven trials indicate that mirtazapine leads to higher … change weight gains than citalopram, fluoxetine, paroxetine, and sertraline.

279. Validity and Inter-rater Reliability Testing of Quality Assessment Instruments | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/quality-tools-testing/research
     March 20, 2012 - Validity and Inter-rater Reliability Testing of Quality Assessment Instruments Research Report March 20, 2012 Web Version [NLM Site] Download Main Document PDF 1.3 MB People using assistive technology may not be able to fully access information in this file. For additional assistance, please contact us…

280. Transparency of Reporting Requirements Project: Management of Infertility | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/transparency-infertility/research-protocol
     September 03, 2016 - Polycystic Ovary Syndrome/therapy"[Mesh] OR "Endometriosis/therapy"[Mesh] OR "Nutrition Therapy"[Mesh] OR "Weight … tiab] OR “Firmagon”[tiab] OR “ganirelix”[tiab] OR “antagon”[tiab] OR exercise[tiab] OR diet[tiab] OR “weight … Interventions Clomiphene citrate, letrozole, diet/exercise/other weight loss strategies, timed intercourse